Krystal Biotech Inc (KRYS)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. John C. ThomasEVP, General Counsel & Corporate Secretary | -642.00 | 193.90k | Automatic Disposition | 302.03 | 0.00 | -100.00% |
| 2026-03-04 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -24.59k | 6.48M | 売り | 258.54 - 266.42 | 1.49M | -1.62% |
| 2026-03-04 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -407.00 | 104.73k | Automatic Disposition | 257.32 | 1.49M | -0.03% |
| 2026-03-04 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -483.00 | 124.28k | Automatic Disposition | 257.31 | 1.48M | -0.03% |
| 2026-03-04 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -24.52k | 6.45M | 売り | 258.38 - 266.56 | 1.48M | -1.63% |
| 2026-02-27 | Ms. Kathryn A. RomanoExec. VP & CAO | 7.50k | 0.00 | Derivative Exercise and Retained Stock | - | 22.37k | 50.45% |
| 2026-02-27 | Ms. Kathryn A. RomanoExec. VP & CAO | -550.00 | 149.11k | Derivative Exercise and Sale | 267.60 - 275.64 | 22.37k | - |
| 2026-03-02 | Ms. Kathryn A. RomanoExec. VP & CAO | -440.00 | 117.74k | Automatic Disposition | 267.60 | 22.37k | -1.93% |
| 2026-02-27 | Ms. Kathryn A. RomanoExec. VP & CAO | -3.26k | 899.14k | Sale to Issuer | 275.64 | 22.37k | -12.73% |
| 2026-02-27 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | 22.20k | 0.00 | Derivative Exercise and Retained Stock | - | 1.59M | 1.42% |
| 2026-02-27 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -18.53k | 5.11M | Derivative Exercise and Sale | 275.64 | 1.59M | - |
| 2026-02-27 | Ms. Suma M. KrishnanFounder, President of R&D and Director | 14.44k | 0.00 | Derivative Exercise and Retained Stock | - | 1.52M | 0.96% |
| 2026-02-27 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -12.06k | 3.32M | Derivative Exercise and Sale | 275.64 | 1.52M | - |
| 2026-02-27 | Alta Bioequities法人 | -11.80k | 3.25M | Automatic Disposition | 275.45 - 276.17 | 73.29k | -13.87% |
| 2026-02-24 | Mr. Daniel S. JanneyLead Independent Director | -37.90k | 10.02M | Derivative Exercise and Sale | 2.46 - 271.09 | 0.00 | - |
| 2026-02-24 | Alta Bioequities法人 | -22.27k | 6.04M | Automatic Disposition | 263.05 - 276.32 | 85.10k | -20.74% |
| 2026-02-19 | Mr. Dino A. RossiIndependent Director | -18.95k | 4.79M | Derivative Exercise and Sale | 8.79 - 262.10 | 78.69k | - |
| 2026-02-09 | Ms. Kathryn A. RomanoExec. VP & CAO | -12.50k | 2.61M | Derivative Exercise and Sale | 63.55 - 277.88 | 18.57k | - |
| 2026-02-09 | Ms. Kathryn A. RomanoExec. VP & CAO | -750.00 | 0.00 | Other Disposition | - | 18.57k | -3.88% |
| 2025-12-04 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -25.00k | 5.50M | Automatic Disposition | 214.28 - 222.20 | 1.57M | -1.57% |
| 2025-12-05 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -5.00k | 0.00 | Other Disposition | - | 1.57M | -0.32% |
| 2025-12-04 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -25.00k | 5.50M | Automatic Disposition | 214.25 - 222.38 | 1.50M | -1.64% |
| 2025-07-14 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -18.00k | 2.71M | Automatic Disposition | 150.00 - 151.79 | 1.53M | -1.16% |
| 2025-07-14 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -17.87k | 2.69M | Automatic Disposition | 150.00 - 151.79 | 1.51M | -1.17% |
| 2025-07-09 | Ms. Suma M. KrishnanFounder, President of R&D and Director | -7.00k | 1.05M | Automatic Disposition | 150.14 - 151.39 | 1.55M | -0.45% |
| 2025-07-09 | Mr. Krish S. KrishnanFounder, Chairman, President & CEO | -7.13k | 1.07M | Automatic Disposition | 150.07 - 151.39 | 1.53M | -0.46% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。